Last Updated IST
Representative image. Credit: AFP Photo
Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
The companies said in a statement the mRNA-based combination vaccine candidate was set to progress to a phase one trial in the United States with 180 volunteers.
Deccan Herald is on WhatsApp Channels| Join now for Breaking News & Editor's Picks